Latest News
Base Resources receives takeover bid from Energy Fuels to create global critical minerals group
US-based critical minerals producer Energy Fuels has made a takeover bid for Australian company Base Resources (AIM: BSE) to create a billion-dollar global business with a focus on rare earth elements, uranium and mineral sands production. Under the terms of the proposal, Base shareholders will receive 0.026 Energy Fuels shares for each Base share held […]
Keywords Studios sees revenue jump following strategic acquisitions
Irish video game service provider Keywords Studios (LSE: KWS) has cited robust organic growth and multiple acquisitions for a 13% jump in 2023 full-year revenue to approximately £666 million, from £590 million in the previous year. The company’s adjusted operating profit rose 6% to £104 million with a 15.6% margin, which was ahead of its […]
Mike Ashley joins Hornby as consultant amid Frasers Group’s increased stake
International models and collectibles group Hornby has engaged retail tycoon Mike Ashley as a consultant to the company. The appointment comes one month after it was revealed that Mr Ashley’s company Frasers Group had upped its stake as a strategic shareholder. Mr Ashley will provide the services to the toy company through his wholly-owned company […]
Poolbeg Pharma moves closer to granting of patent for POLB 001 to treat multiple diseases
UK biopharmaceutical company Poolbeg Pharma (AIM: POLB) has received a notice of allowance from the US Patent Office in relation to an application for its lead candidate POLB 001 in the treatment of multiple diseases. The notice covers a class of drugs (including POLB 001) for treating hypercytokinaemia (cytokine storm) and for preventing its development […]
Diversified Energy to lift interests in US oil and gas assets
London and New York-listed Diversified Energy Company (LSE: DEC) has entered into a conditional agreement with Oaktree Capital Management for the strategic acquisition of working interests in a number of operated assets in the Central Region of the US. The US$386 million acquisition will consolidate Diversified’s working interest in its existing operated wells in the […]
Faron Pharma reports improved remission rates from Bexmab Phase 1 trial to treat patients with aggressive cancers
Faron Pharmaceuticals (LSE: FARN) has reported positive data from Phase 1 of an ongoing trial investigating bexmarilimab (Bexmab) in combination with standard of care in aggressive hematological malignancies of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Four out of five initial Phase 1 patients have now been on Bexmab with azacitidine for more than […]
Sign In Solutions makes £28.35m cash bid for SmartSpace Software
Sign In Solutions subsidiary Welcome UK Bidco has made a £28.35 million cash offer for technology business SmartSpace Software (LSE: SMRT) by way of a court-sanctioned scheme of arrangement. SmartSpace designs and builds smart software solutions such as visitor, desk and meeting room management to help transform employee engagement. Under the terms of the deal, […]
Vodafone Group to divest Italian business in US$8.71b deal with Swisscom
Vodafone Group Plc (LSE: VOD) has announced it will divest its subsidiary Vodafone Italy to Switzerland-based telco Swisscom AG. The US$8.71 billion transaction follows an extended period of engagement with several companies to explore market consolidation options in Italy. It comes hot on the heels of Vodafone Spain’s divestment in October to Zegona Communications plc […]
China’s JD.com becomes second suitor to walk away from takeover bid for Currys
Chinese e-commerce giant JD.com (also known as Jingdong) has walked away from a takeover tussle for British appliance and electronics chain Currys plc (LSE: CURY). In a brief statement released last week, the company said it would no longer pursue an offer for the High Street brand, less than one month after entering the race. […]
Ondine Biomedical’s Steriwave antimicrobial to be rolled out in eight new healthcare facilities
Ondine Biomedical (LSE: OBI) has announced that its Steriwave nasal photodisinfection and chlorhexidine skin decolonisation technology will be deployed in eight new healthcare facilities worldwide, including six hospitals. The commercial deals are paid adoptions which had begun or were agreed to before the end of February. The first three are at hospitals in Spain and […]
AstraZeneca spends US$1.05b to acquire Amolyt Pharma and boost its rare disease portfolio
Global pharmaceutical company AstraZeneca (LSE: AZN) will part with US$1.05 billion to buy-out French biotech Amolyt Pharma, which is focused on the development of novel treatments for rare endocrine diseases. Under the terms of the transaction, AstraZeneca will acquire all of Amolyt’s outstanding shares on a cash and debt-free basis. It will include an US$800 […]
NetScientific reports profitable year ahead of shift in venture capital trends to deep tech
Deep tech and life sciences venture capital investment group NetScientific plc (LSE: NSCI) has lodged a proprietary trade profit of approximately £427,000 and an increase in capital under advisory to £23.5 million for the year ended 31 December. The group – which has a portfolio of 23 companies — also reported the raising of £52.2 […]
Copper prices climb to 11-month high on the back of supply setbacks and rising demand
While the price of copper may not be filling the headlines that gold is creating, the red metal is tipped to be one of the best investments in commodity markets this year. Copper is sitting around $6.05 per pound this week. That’s up 3.77% since the beginning of the year and new market activity and […]